Category | Cohort 1 (n = 391) | Cohort 2 (n = 456) | Combined (n = 847) |
---|---|---|---|
Age, y, median (range) | 57 (22–87) | 53 (21–87) | 55 (21–87) |
Normal | |||
 Normal screening mammogram | 223 | 145 | 368 |
Call-Back | |||
 Normal Diagnostic Mammogram | 81 | 83 | 164 |
Cases | |||
 Biopsy Confirmed Breast Cancer | 87 | 21 | 108 |
IDC | 48 | 14 | 62 |
ILC | 4 | 3 | 7 |
DCIS | 20 | 2 | 22 |
Multiple | 4 | 0 | 4 |
Other | 11 | 2 | 13 |
Grade | |||
 Low | 18 | 2 | 20 |
 Intermediate | 41 | 11 | 52 |
 High | 26 | 7 | 33 |
 Unknown | 2 | 1 | 3 |
Tumor Size (cm) | |||
  < 1 | 28 | 3 | 31 |
 1–2 | 27 | 11 | 38 |
  > 2 | 29 | 7 | 36 |
 Multiple | 9 | 2 | 11 |
 Primary tumor with positive node | 15 | 2 | 17 |
 Unknown | 3 |  | 3 |
Receptor Status | |||
 ER−/PR- | 1 | 1 | 2 |
 ER−/PR+ | 1 | 0 | 1 |
 ER+/PR+ | 16 | 2 | 18 |
 ER+/PR- | 3 | 0 | 3 |
 ER−/PR−/HER2+ | 3 | 0 | 3 |
 ER+/PR+/HER2- | 47 | 13 | 60 |
 ER+/PR−/HER2- | 4 | 1 | 5 |
 ER+/PR+/HER2+ | 8 | 2 | 10 |
 Triple Negative | 4 | 2 | 6 |
Benign | Â | 121 | Â |
Category 3 | Â | 86 | Â |